As healthcare professionals, a deep understanding of neurodegenerative disorders is vital, and Parkinson's disease (PD) is one of the most prevalent. PD affects nearly 1% of individuals over 60 years old, making it a significant concern in geriatric care.
PD is a multifactorial disease with both genetic and environmental influences. The specific cause remains unknown, but it is characterized by the loss of dopaminergic neurons in the substantia nigra. This loss leads to a decrease in dopamine levels, causing motor and non-motor symptoms.
PD is often recognized by its cardinal motor symptoms: bradykinesia, resting tremor, rigidity, and postural instability. Non-motor symptoms such as cognitive impairment, depression, and autonomic dysfunction can also be present and significantly impact patients' quality of life.
Diagnosis of PD is primarily clinical, based on history and physical examination. Currently, there are no definitive diagnostic tests, but imaging studies like DaTSCAN can provide supportive evidence. Early diagnosis is crucial for timely management.
Treatment of PD is symptomatic, aiming to improve quality of life. Pharmacological therapy with levodopa remains the gold standard. Non-pharmacological interventions, including physical therapy and deep brain stimulation, can also be beneficial.
PD is a progressive disorder with a variable course. Factors influencing prognosis include age at onset, rate of disease progression, and presence of non-motor symptoms. Regular follow-up is essential to adjust treatment plans and manage complications.
Understanding Parkinson's disease is essential for healthcare professionals. While it remains a complex and challenging disease to manage, advances in research continue to provide new insights into its pathophysiology, diagnosis, and treatment. Continued education on PD will ensure we deliver the best possible care to our patients.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation